date:Apr 24, 2013
ial risk for developing obesity-related liver disease in their lifetimes.
Dr Manor and his team studied a group of mice that were in the advanced stage of non-alcoholic steatohepatitis.
Known as NASH for short, this is a common complication of obesity characterised by fat accumulation and inflammation in the liver.
It is most common in people who are obese, have type 2 diabetes, have high blood pressure or high cholesterol.
It is the most severe form of non-alcoholic fatty liver disease and